Epidemiology of Metabolic Dysfunction-Associated Steatotic Liver Disease
Zobair M. Younossi, Markos Kalligeros, Linda Henry
Received 2024 Jun 6 Accepted 2024 Aug 15 Published online 2024 Aug 19 DOI: https://doi.org/10.3350/cmh.2024.0431
[Accepted] |
Citations to this article as recorded by
Association of sleep patterns and disorders with metabolic dysfunction-associated steatotic liver disease and liver fibrosis in contemporary American adults
Guannan Zong, Wangjia Mao, Ming Wen, Xiaoyun Cheng, Guanghui Liu
Annals of Hepatology.2025; 30(2): 101583. CrossRef Kidney function mediates the association of per- and poly-fluoroalkyl substances (PFAS) and heavy metals with hepatic fibrosis risk
Zhengqi Wei, Jincheng Liu, Na Wang, Keke Wei
Environmental Research.2024; 263: 120092. CrossRef Assessing Mortality Disparities Among Non-Alcoholic Fatty Liver Disease Metabolic Dysfunction Fatty Liver Disease and Metabolic Dysfunction-Associated Liver Disease: A Comprehensive Meta-Analysis
Fahad Lakhdhir, Agha Syed Muhammad, Ahmed Nasir Qureshi, Imran A Shaikh, Imran Joher, Jawaria Majeed, Javaria Khan
Cureus.2024;[Epub] CrossRef Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality
Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
Clinical and Molecular Hepatology.2024; 30(4): 982. CrossRef
|